Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset

Molecular Human Reproduction

Volumn 13, Issue 10, 2007, Pages 729-736

  Taylor, P D ^a   Wilson, H ^a   Hillier, S G ^a   Wiegand, S J ^b   Fraser, H M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Angiogenesis; Follicle; Marmoset monkey; Ovary; VEGF Trap

Indexed keywords

CASPASE 3; ESTRADIOL; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; ENDOTHELIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICLE CYST; FOLLICULAR PHASE; INCIDENCE; LUTEAL PHASE; MARMOSET; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL;

ANIMALS; CALLITHRIX; CELL PROLIFERATION; CORPUS LUTEUM; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; FOLLICULAR ATRESIA; FOLLICULAR PHASE; IMMUNOGLOBULIN FC FRAGMENTS; LUTEAL PHASE; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN FOLLICLE; OVARY; PROGESTERONE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MARMOSETS;

EID: 35148855012     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam056     Document Type: Article

References (30)

1. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 2002;174:1-5.
2. Agrawal R, Jacobs H, Payne N, Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 2002;78:1164-1169.
3. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2003;39:225-237.
4. Dvorak HF, Nagy JA, Feng D. Vascular permeability factor/vascular endothelial growth factor and the significance of micro-vascular hyper-permeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97-132.
5. Fraser HM, Dickson SE, Morris KD, Erickson GF, Lunn SF. The effects of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. Hum Reprod 1999;14:2054-2060.
6. Fraser HM, Wilson H, Rudge JS, Wiegand SJ. Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function. J Clin Endocrinol Metab 2005;90:1114-1122.
7. Fraser HM, Wilson H, Wulff C, Rudge JS, Wiegand SJ. Administration of vascular endothelial growth factor trap in the 'post angiogenic' period of the luteal phase causes rapid functional luteolysis and endothelial death in the marmoset. Reproduction 2006;132:589-600.
8. Gilchrist RB, Wicherek M, Heistermann M, Naydu PL, Hodges JK. Changes in follicle stimulating hormone and follicle populations during the ovarian cycle of the common marmoset. Biol Reprod 2001;64:127-135.
9. Gomez R, Simon C, Remohi J, Pellicer A. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003;68 2164-2171.
10. Gomez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology 2002;143:4339-4348.
11. Gosden RG, Hunter RH, Telfer E, Torrance C, Brown N. Physiological factors underlying the formation of ovarian follicular fluid. J Reprod Fertil 1988;82:813-825.
12. Greenaway JB, Connor K, Pedersen HG, Coomer BL, LaMarre J, Petrik J. Vascular endothelial growth factor and its receptor, Flk-1/KDR are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 2004;145:2896-2905.
13. Harlow CR, Hearn JP, Hodges JK. Ovulation in the marmoset monkey: endocrinology, predication and detection. J Endocrinol 1984;103 17-24.
14. Holash J, Davis S, Papadopoulos N. VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 2002;99 11393-11398.
15. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673-700.
16. Koos RD. Increased expression of vascular endothelial growth permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: Potential roles in follicle rupture. Biol Reprod 1995; 52:1426-1435.
17. McConnell NA, Yunus RS, Gross SA, Bost KL, Clemens MG, Hughes FM, Jr. Water permeability of an ovarian antral follicle is predominantly transcellular and mediated by aquaporins. Endocrinology 2002; 143:2905-2912.
18. Pan HA, Wu MH, Cheng YC, Li CH, Chang FM. Quantifitation of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: A possible new marker for diagnosis. Hum Reprod 2002;17:201-206.
19. Paranezhad ME, Bagheri H, Alborzi S, Schmidt EH. Ovarian stromal blood flow changes after laparoscopic ovarian cauterisation in women with polycystic ovarian syndrome. Hum Reprod 2003;18:1432-1437.
20. Roberts WG, PaLade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-2379.
21. Summers PM, Wennink J, Hodges JK. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). J Reprod Fertil 1985;73 133-138.
22. Taylor PD, Hillier SG, Fraser HM. Effects of GnRH antagonist treament on follicular development and angiogenesis in the primate ovary. J Endocrinol 2004;187:1-17.
23. Thomas F, Telfer E, Fraser HM. Expression of anti-mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. Endocrinology 2007;148:2273-2281.
24. Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 2002;87:3300-3308.
25. Wulff C, Wiegand SJ, Saunders PTK, Scobie GA, Fraser HM. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1Fc (vascular endothelial growth factor trapA40). Endocrinology 2001a;142:3244-3254.
26. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM. Luteal angiogenesis: Prevention and intervention by treatment with vascular endothelial growth factor trap A40. J Clin Endocrinol Metab 2001b;86:3377-3386.
27. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2. Endocrinology 2002;143:2797-2807.
28. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 2003;112:659-669.
29. Zimmermann RC, Xiao E, Bohlen P, Ferin M. Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology 2002;143:2496-2502.
30. Zimmermann RC, Xiao E, Husami N, Sauer MV, Lobo R, Kitajewski J, Ferin M. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. J Clin Endocrinol Metab 2001;86:768-772.